Pharma company Wockhardt, which has close to Rs 3,400 crore in debt, today said that the corporate debt restructuring (CDR) process in the company is likely to be over in the next four to six weeks.
"The corporate debt restructuring may be ready in a week's time. After which, within four to six weeks, we should sign an agreement" to that effect, Wockhardt Chairman Habil Khorakiwala told reporters here after the company's AGM here.
A couple of months ago, the company had asked ICICI Bank to restructure its debt.
CDR is restructuring of a company's outstanding obligations often achieved by reducing the burden of the debts on the company by decreasing the rates paid and increasing the time the company has to pay the obligations.
The drugmaker's foreign currency convertible bonds (FCCB) are due for payment in October.
"We are restructuring our FCCBs too. We have started talking to our FCCB lenders. We have more than one more option available," he said.
The company may look at buyback of some of the FCCBs, he added, after which, within four to six weeks, it would sign an agreement to that effect.
The face value of FCCBs stands at $109 million.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
